Fingerprint
Dive into the research topics of 'Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin ≥ 100 mg/m2'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin ≥ 100 mg/m2
M. G. Kris, R. A. Clark, L. B. Tyson, W. F. Hahne, K. M.W. Pisters, R. J. Gralla
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations